A. Aupérin, L. Péchoux, C. , R. E. Curran, W. Furuse et al., Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non???Small-Cell Lung Cancer, Journal of Clinical Oncology, vol.28, issue.13, pp.2181-190, 2010.
DOI : 10.1200/JCO.2009.26.2543

M. Kwint, W. Uyterlinde, J. Nijkamp, C. Chen, J. De-bois et al., Acute Esophagus Toxicity in Lung Cancer Patients After Intensity Modulated Radiation Therapy and Concurrent Chemotherapy, International Journal of Radiation Oncology*Biology*Physics, vol.84, issue.2, pp.223-231, 2012.
DOI : 10.1016/j.ijrobp.2012.03.027

A. Mauguen, L. Péchoux, C. Saunders, M. Schild, S. Turrisi et al., Hyperfractionated or Accelerated Radiotherapy in Lung Cancer: An Individual Patient Data Meta-Analysis, Journal of Clinical Oncology, vol.30, issue.22, pp.2788-97, 2012.
DOI : 10.1200/JCO.2012.41.6677

J. Belderbos, L. Uitterhoeve, N. Van-zandwijk, H. Belderbos, P. Rodrigus et al., Randomised trial of sequential versus concurrent chemo-radiotherapy in patients with inoperable non-small cell lung cancer (EORTC 08972-22973), European Journal of Cancer, vol.43, issue.1, pp.114-135, 2007.
DOI : 10.1016/j.ejca.2006.09.005

A. Eisbruch, J. Harris, A. Garden, C. Chao, W. Straube et al., Multi-Institutional Trial of Accelerated Hypofractionated Intensity-Modulated Radiation Therapy for Early-Stage Oropharyngeal Cancer (RTOG 00-22), International Journal of Radiation Oncology*Biology*Physics, vol.76, issue.5, pp.1333-1341, 2010.
DOI : 10.1016/j.ijrobp.2009.04.011

L. Crinòcrin-`-crinò, W. Weder, J. Van-meerbeeck, and E. Felip, Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Annals of Oncology, vol.21, issue.Supplement 5, pp.103-118, 2010.
DOI : 10.1093/annonc/mdq207

L. Péchoux and C. , Role of Postoperative Radiotherapy in Resected Non-Small Cell Lung Cancer: A Reassessment Based on New Data, The Oncologist, vol.16, issue.5, pp.672-81, 2011.
DOI : 10.1634/theoncologist.2010-0150

C. Chen, W. Uyterlinde, J. Sonke, J. De-bois, M. Van-den-heuvel et al., Severe late esophagus toxicity in NSCLC patients treated with IMRT and concurrent chemotherapy, Radiotherapy and Oncology, vol.108, issue.2, pp.337-378, 2013.
DOI : 10.1016/j.radonc.2013.08.017

Z. Jiang, K. Yang, R. Komaki, X. Wei, S. Tucker et al., Long-Term Clinical Outcome of Intensity-Modulated Radiotherapy for Inoperable Non-Small Cell Lung Cancer: The MD Anderson Experience, International Journal of Radiation Oncology*Biology*Physics, vol.83, issue.1, pp.332-341, 1963.
DOI : 10.1016/j.ijrobp.2011.06.1963

T. Schytte, T. Nielsen, C. Brink, and O. Hansen, Pattern of loco-regional failure after definitive radiotherapy for non-small cell lung cancer, Acta Oncologica, vol.53, issue.3
DOI : 10.3109/0284186X.2013.813635

S. Senan, J. Burgers, and M. Samson, Can elective nodal irradiation be omitted in stage III non-small-cell lung cancer? analysis of recurrences in a phase II study of induction chemotherapy and involved-field radiotherapy, International Journal of Radiation Oncology*Biology*Physics, vol.54, issue.4, pp.999-1006, 2002.
DOI : 10.1016/S0360-3016(02)03028-6

S. Senan, O. Chapet, F. Lagerwaard, T. Haken, and R. , Defining target volumes for non-small cell lung carcinoma, Seminars in Radiation Oncology, vol.14, issue.4, pp.308-322, 2004.
DOI : 10.1016/j.semradonc.2004.07.004

T. Kimura, T. Togami, and Y. Nishiyama, Impact of Incidental Irradiation on Clinically Uninvolved Nodal Regions in Patients With Advanced Non-Small-Cell Lung Cancer Treated With Involved-Field Radiation Therapy: Does Incidental Irradiation Contribute to the Low Incidence of Elective Nodal Failure?, International Journal of Radiation Oncology*Biology*Physics, vol.77, issue.2, pp.337-380, 2010.
DOI : 10.1016/j.ijrobp.2009.05.039

Y. Lievens, A. Nulens, A. Gaber, M. Defraene, G. et al., Intensity-Modulated Radiotherapy for Locally Advanced Non???Small-Cell Lung Cancer: A Dose-Escalation Planning Study, International Journal of Radiation Oncology*Biology*Physics, vol.80, issue.1, pp.306-319, 2011.
DOI : 10.1016/j.ijrobp.2010.06.025

J. Bradley, R. Paulus, R. Komaki, G. Masters, G. Blumenschein et al., Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study, The Lancet Oncology, vol.16, issue.2, pp.187-99, 2015.
DOI : 10.1016/S1470-2045(14)71207-0